risks of glp-1 GI Adverse Effects Glucagon-Like Peptide-1 Receptor Agonists The expanding role of GLP-1
Description
The combination of slowing digestion, reducing blood sugar, and decreasing appetite helps weight loss
doi: 10.1371/journal.pone.0107391 146 MaSWBenzieIFFChuTTWFokBSPTomlinsonBCritchleyLAH
174 Currently, Eli Lilly has initiated a Phase III development program to further investigate the efficacy and safety of orforglipron in treating obesity, overweight, and T2DM
Why Aspiration Risk Is a Growing Concern Aspiration occurs when stomach contents enter the lungs during anesthesia, potentially leading to pneumonia or other complications
Supported by trials like EMPA-REG, LEADER, and CANVAS, though large dedicated combination trials are still ongoing.
Standard occupational or insurance-related urine drug tests will not detect Ozempic
